Health Care Cost Associated With Prostate Cancer, Androgen Deprivation Therapy and Bone Complications

التفاصيل البيبلوغرافية
العنوان: Health Care Cost Associated With Prostate Cancer, Androgen Deprivation Therapy and Bone Complications
المؤلفون: Onur Baser, Stacey R. Long, Mark S. Litwin, D. Macarios, Tracey L. Krupski, Kathleen A. Foley
المصدر: Journal of Urology. 178:1423-1428
بيانات النشر: Ovid Technologies (Wolters Kluwer Health), 2007.
سنة النشر: 2007
مصطلحات موضوعية: Oncology, Gynecology, Nephrology, medicine.medical_specialty, Bone density, business.industry, Urology, Osteoporosis, Disease, medicine.disease, Hormone antagonist, Comorbidity, Androgen deprivation therapy, Prostate cancer, Internal medicine, medicine, business
الوصف: Purpose: We ascertained the health care costs of androgen deprivation therapy and related skeletal events.Materials and Methods: Using data from the MarketScan Medicare Supplemental and Coordination of Benefits Database, we identified cases with International Classification of Disease, 9th Revision codes indicating a diagnosis of prostate cancer who initiated androgen deprivation therapy between 1999 and 2002. The control group consisted of patients with prostate cancer with no androgen deprivation therapy use, matched by age, geographic region, insurance plan and index year. All had followup data for at least 36 months. The occurrence and cost of osteoporosis and any bone fracture were assessed using a propensity score matched sample.Results: Of the 8,577 eligible men with prostate cancer, 3,055 initiated androgen deprivation therapy and 5,522 did not. At the time of androgen deprivation therapy initiation those on androgen deprivation therapy had more severe comorbidity (3.1 vs 2.6, p
تدمد: 1527-3792
0022-5347
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::2e252c00c99e6647e2dfd7a406c4356a
https://doi.org/10.1016/j.juro.2007.05.135
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........2e252c00c99e6647e2dfd7a406c4356a
قاعدة البيانات: OpenAIRE